Mesa Laboratories down on lower-than-estimated Q3 earnings
** Shares of Mesa Laboratories Inc MLAB.O up 3.9% at $190
- biggest pct loss in nearly three months
** Co reported Q3 2023 sales of $54.28 mln, missing
analysts' estimate of $57.74 mln - Refinitiv data urn:newsml:reuters.com:*:nGNX1WFhMC
** Q3 adj. profit was $0.08/shr, lower than analysts'
estimate of $0.14 - Refinitiv data
** In 2022, MLAB was down ~49%
(Reporting by Khushi Mandowara in Bengaluru)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on Mesa Laboratories
See all newsMesa Laboratories, Inc. reports results for the quarter ended September 30 - Earnings Summary
Mesa Laboratories Q2 revenue rises on divisional performance
Mesa Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary
Mesa Labs Q1 revenue rises as calibration, biopharma units grow
Mesa Laboratories, Inc. expected to post earnings of 3 cents a share - Earnings Preview